Efficacy of Low-Dose Interleukin-2 Examined Across Autoimmune Diseases
Researchers assessed the safety, biologic, and clinical effects of low-dose interleukin-2 across 11 individual diseases chosen to represent the whole spectrum of autoimmune or inflammatory chronic diseases.